tradingkey.logo

Biote Corp

BTMD
查看详细走势图
2.230USD
+0.110+5.19%
收盘 02/06, 16:00美东报价延迟15分钟
68.42M总市值
2.46市盈率 TTM

Biote Corp

2.230
+0.110+5.19%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+5.19%

5天

+6.70%

1月

-8.98%

6月

-23.63%

今年开始到现在

-14.23%

1年

-51.10%

查看详细走势图

TradingKey Biote Corp股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Biote Corp当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力较大。当前估值合理,在专业与商业服务行业排名83/156位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价4.84。中期看,股价处于平稳状态。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Biote Corp评分

相关信息

行业排名
83 / 156
全市场排名
231 / 4521
所属行业
专业与商业服务

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Biote Corp亮点

亮点风险
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
业绩高增长
公司营业收入稳步增长,连续3年增长19.54%
估值低估
公司最新PE估值2.46,处于3年历史低位
机构减仓
最新机构持股20.37M股,环比减少0.13%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值2.54K
活跃度增加
近期活跃度增加,过去20天平均换手率0.51

分析师目标

根据 5 位分析师
买入
评级
4.843
目标均价
+118.17%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Biote Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Biote Corp简介

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
公司代码BTMD
公司Biote Corp
CEOChristensen (Bret)
网址https://haymakeracquisition.com/
KeyAI